Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Feb 16, 2024
Episode
204 - Spanish
Soundcloud
Share
The IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2017 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in eight different languages. In this episode, Dr. Narjust Florez discusses the importance of this survey and some of the barriers to biomarker testing in Spanish with Dr. Ivy Riano and Dr. Teresa Gorría. To take the survey, visit: https://bit.ly/BiomarkerS24
Guest
Ivy Riano
MD
Hematology and Medical Oncology Fellow and Research Chief Fellow
Dartmouth Cancer Center
Teresa Gorría
MD
Medical Oncologist
Hospital Clínic, Barcelona
